摘要
BACKGROUND:Continuous lamivudine therapy is associated with high rates of YMDD mutations,which are the main causes of drug resistance.The current study explores the association of the emergence of YMDD mutations with pretherapy HBV genotype,HBV-DNA levels,HBeAg status,and serum alanine aminotransferase(ALT) levels in Chinese patients receiving lamivudine therapy for chronic hepatitis B.METHODS:A total of 319 chronic hepatitis B patients who received lamivudine therapy for more than a year were enrolled in t...
学科与关键词
关键词
YMDD mutationslamivudine therapychronic hepatitis BHBV genotype
- 慢性乙型肝炎患者YMDD突变与HBV DNA定量水平相关性研究张笠; 高武; 刘小荣国际检验医学杂志, 2012, (22): 2724-2725.
- 核苷(酸)类似物联合中药治疗HBV-P基因序列耐药变异研究陈星浩; 宋洁; 石玉珍; 肖仁飞; 唐蒙轩; 谭小芸; 付新昆临床合理用药杂志, 2013, (05): 1-2.
- 356例乙型肝炎患者病毒分型及拉米夫定治疗所致耐药突变株变化分析李延武; 李卓成实用临床医药杂志, 2013, (13): 27-29.
